Active Chemistry Engineering

EPSRC Centre for Doctoral Training in Molecular Sciences for Medicine

In plain English

AI plain-English summary

A new doctoral training centre will embed chemists, biophysicists, and molecular biologists directly into medical research teams to tackle unmet health needs—from understanding disease biology to designing new cancer therapies. The programme addresses a persistent gap: molecular scientists and medical researchers often work in separate silos, slowing the translation of fundamental discoveries into treatments. By training a cohort of researchers who are equally fluent in both worlds, the centre aims to produce graduates who can bridge that divide. If successful, the centre will supply the UK’s pharmaceutical and biotech industries—which currently employ nearly 500,000 people nationally—with a pipeline of leaders skilled in both molecular science and drug development. The research will focus on three themes: disease biology, molecule and assay design, and structural biology and computation. Projects will be co-designed with industrial partners, giving priority to those with commercial relevance. Students will also receive training in entrepreneurship and project management. The centre is a joint programme between Newcastle and Durham Universities, drawing on their combined expertise in areas such as approved cancer treatments.

View original technical description
Molecular sciences, such as chemistry, biophysics, molecular biology and protein science, are vital to innovations in medicine and the discovery of new medicines and diagnostics. As well as making a crucial contribution to health and society, industries in this field provide an essential component to the economy and contribute hugely to employment figures, currently generating nearly 500,000 jobs nationally. To enable and facilitate future economic growth in this area, the CDT will provide a cohort of researchers who have training in both aspects of this interface who will be equipped to become the future innovators and leaders in their field. All projects will be based in both molecular and medical sciences and will focus on unmet medical needs, such as understanding of disease biology, identification of new therapeutic targets, and new approaches to discovery and development of novel therapies. Specific problems will be identified by researchers within the CDT, industrial partners, stakeholders and the CDT students. The research will be structured around three theme areas: Biology of Disease, Molecule and Assay Design and Structural Biology and Computation. The CDT brings together leading researchers with a proven track record across these areas and who have pioneered recent advances in the field, such as multiple approved cancer treatments. Their combined expertise will provide supervision and mentorship to the student cohort who will work on projects that span these research themes and bring their contributions to bear on the medical problems in question. The student cohort approach will allow teams of researchers to work together on joint projects with common goals. Projects will be proposed between academics, industrial partners and students with priority given to those with industrial relevance. The programme of research and training across the disciplines will equip graduates of the CDT with an unprecedented background of knowledge and skills across the disciplines. The programme of research and training across the disciplines will be supplemented by training and hands-on experiences of entrepreneurship, responsible innovation and project management. Taken together this will make graduates of the CDT highly desirable to employers, equip them with the skills they need to envisage and implement future innovations in the area and allow them to become the leaders of tomorrow. A structured and highly experienced management group, consisting of a director, co-directors, theme leads and training coordinators will oversee the execution of the CDT with the full involvement of industry partners and students. This will ensure delivery of the cohort training programme and joint events as well as being accountable for the process of selection of projects and student recruitment. The management team has an established track record of delivery of research and training in the field across industry and academia as well as scientific leadership and network training coordination. The CDT will be delivered as a single, fully integrated programme between Newcastle and Durham Universities, bringing together highly complementary skills and backgrounds from the two institutions. The seamless delivery of the programme across the two institutions is enabled by their unique connectivity with efficient transport links and established regional networks. The concept and structure of the CDT has been developed in conjunction with the industrial partners across the pharmaceutical, biotech and contract research industries, who have given vital steer on the desirability and training need for a CDT in this area as well as to the nature of the theme areas and focus of research. EPSRC funding for the CDT will be supplemented by substantial contributions from both Universities with resources and studentship funding and from industry partners who will provide training, in kind contribution and placements as well as additional studentships.

View the original record at the funder ↗

Researchers

Agnieszka Bronowska (Co-Investigator)Celine Cano (Co-Investigator)Ehmke Pohl (Co-Investigator)Jacquie Robson (Co-Investigator)Matthias Trost (Co-Investigator)Paul Denny (Co-Investigator)Simi Ali (Co-Investigator)Steven Cobb (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

EPSRC Centre for Doctoral Training in Molecules to Product
EPSRC Centre for Doctoral Training in Synthesis for Biology and Medicine
EPSRC Centre for Doctoral Training in Advanced Therapeutics & Nanomedicines
'EPSRC and SFI Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine
EPSRC Centre for Doctoral Training in Chemical Biology: Empowering UK BioTech Innovation

Original classification

Training Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.